NIH-funded research R01 grant

Understanding how NRF2 activation affects cilia in airway diseases

Official title: NRF2 activation program in normal and immotile cilia

Funded at Washington University · NIH-11118689 · Data updated 2026-11-12

This study is looking at how a specific pathway in our cells affects tiny hair-like structures that help keep our lungs healthy, and it's specifically for people with primary ciliary dyskinesia (PCD), a condition that makes these structures not work properly; the researchers want to find out how genes in these cells are different in PCD patients compared to healthy people to discover new ways to help improve treatments for lung problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJune 15, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$635,451
NIH project number5R01HL173490-02
Project IDNIH-11118689 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with primary ciliary dyskinesia or related airway diseases.

Less likely to help

Patients without airway diseases or those not affected by ciliary dysfunction may not benefit from this research.

What this research studies

This research investigates the role of the NRF2 pathway in the function of motile cilia, which are crucial for lung defense. It focuses on patients with primary ciliary dyskinesia (PCD), a genetic condition that leads to impaired cilia function and respiratory issues. By utilizing advanced techniques like single-cell RNA sequencing, the study aims to identify specific gene expression changes in ciliated cells from PCD patients compared to healthy individuals. The goal is to uncover potential therapeutic targets that could improve treatment options for those affected by airway diseases.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for patients with primary ciliary dyskinesia and other airway diseases.

How similar studies have gone: Previous research has shown promise in targeting the NRF2 pathway for various cellular stress responses, indicating potential for success in this novel application.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Horani, Amjad — Washington University
  • Study coordinator: Horani, Amjad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.